Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer. (Q38384387)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Exploiting a novel miR-519c-HuR-ABCG2 regulatory pathway to overcome chemoresistance in colorectal cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

W W Leung

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Simon S M Ng

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

18 September 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

Experimental Cell Research

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

338

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

222-231

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

Global cancer statistics, 2012

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

ABCG2: determining its relevance in clinical drug resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Multiple drug resistance in cancer revisited: the cancer stem cell hypothesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

MicroRNAs: genomics, biogenesis, mechanism, and function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

MicroRNAs play a role in the development of human hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Regulation of ABCG2 expression at the 3' untranslated region of its mRNA through modulation of transcript stability and protein translation by a putative microRNA in the S1 colon cancer cell line.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

MiR-487a resensitizes mitoxantrone (MX)-resistant breast cancer cells (MCF-7/MX) to MX by targeting breast cancer resistance protein (BCRP/ABCG2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

MiR-181a enhances drug sensitivity in mitoxantone-resistant breast cancer cells by targeting breast cancer resistance protein (BCRP/ABCG2).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

RNA stabilization by the AU-rich element binding protein, HuR, an ELAV protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

ABCG2 overexpression in colon cancer cells resistant to SN38 and in irinotecan-treated metastases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Aberrant promoter methylation of the ABCG2 gene in renal carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Overexpression of HuR, a nuclear-cytoplasmic shuttling protein, increases the in vivo stability of ARE-containing mRNAs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

miR-519 reduces cell proliferation by lowering RNA-binding protein HuR levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

miR-519 suppresses tumor growth by reducing HuR levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-alpha mRNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Altered expression of the mRNA stability factor HuR promotes cyclooxygenase-2 expression in colon cancer cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

7 January 2021

ABCG2: a perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

HNS, a nuclear-cytoplasmic shuttling sequence in HuR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

HuR binding to cytoplasmic mRNA is perturbed by heat shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Prognostic role of HuR in hereditary breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Role of the RNA-binding protein HuR in colon carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Increased expression of cytoplasmic HuR in familial adenomatous polyposis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Interplay between microRNAs and RNA-binding proteins determines developmental processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Properties of the Regulatory RNA-Binding Protein HuR and its Role in Controlling miRNA Repression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Downregulation of breast cancer resistance protein in colon adenomas reduces cellular xenobiotic resistance and leads to accumulation of a food-derived carcinogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Down-regulation of BCRP/ABCG2 in colorectal and cervical cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Downregulation of HuR as a new mechanism of doxorubicin resistance in breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

Translational control of TOP2A influences doxorubicin efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2015.09.011

10.1016/J.YEXCR.2015.09.011

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26386386%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference